EUVIMEDEUVIMED entdecken
Crossref

CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease

Jin Chen, Yanping Hao, Ping Xu, Dongxue Bian, Liang Han, Xudong Wu, Zhengjie Zhuang, Jianhua Wang, Yan Luo

Biochemical and Biophysical Research Communications · 2023-07 · 667 · 120-126

DOI: 10.1016/j.bbrc.2023.05.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-07. Verfasst von Jin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangs…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Basic Public Welfare Research Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hepatocyte lipotoxicity mediated by sphingolipids was considered one of important factors in NAFLD development. Knocking out key enzymes for sphingolipids synthesis, such as DES-1, SPHK1 and CerS6, could reduce hepatocyte lipotoxicity and improve NAFLD progression. Previous studies showed that roles of CerS5 and CerS6 in sphingolipids metabolism were similar, but the role of CerS5 was controversial in NAFLD development. This study aimed to clarify the role and mechanism of CerS5 in NAFLD development. METHODS: Hepatocyte conditional CerS5 knockout (CerS5 CKO) and wild type (WT) mice were fed with standard control diet (SC) and choline-deficient, l-amino acid-defined, high-fat diet (CDAHFD) and then divided into four groups: CerS5 CKO-SC, CerS5 CKO-CDAHFD, WT-SC and WT-CDAHFD. RT-PCR, IHC and WB were used to analyze the expression of inflammatory, fibrosis and bile acids (BA) metabolism factors. RNA-seq was used to analyze differences of transcriptional levels of liver molecules among the four groups. Metabolomics was used to measured differences of hepatic BAs among the four groups. RESULTS: Hepatocyte specific knockout of CerS5 did not increase or reduce the severity of 8-weeks CDAHFD induced hepatic steatosis and inflammation, but significantly worsened the progression of liver fibrosis in these mice. At the molecular level, hepatocyte specific knockout of CerS5 did not increase or reduce expression of hepatic inflammatory factors: CD68, F4/80 and MCP-1, but increased expression of hepatic fibrosis factors: α-SMA, COL1α and TGF-β in mice fed with CDAHFD. Transcriptome analysis showed that hepatocyte specific knockout of CerS5 significantly decreased the expression of hepatic cyp27a1, and decreased expression of cyp27a1 was further validated by RT-PCR and WB. Considering that cyp27a1 was a key enzyme in the alternative pathway of BA synthesis, we further found that hepatic BA pools in CerS5 CKO mice were more conducive to the progression of liver fibrosis, which were characterized by elevated hydrophobic 12α-OH BAs and decreased hydrophilic non-12α-OH BAs. CONCLUSION: CerS5 played an important role in the progression of NAFLD related fibrosis, and hepatocyte specific knockout of CerS5 accelerated the progression of NAFLD related fibrosis, which was possibly due to the inhibition of BA synthesis alternative pathway by knocking out hepatocyte CerS5.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsMiceDiet, High-FatDisease Models, AnimalHepatocytesLiverLiver CirrhosisMice, Inbred C57BLSphingosine N-Acyltransferase

Stichwörter der Autor:innen

Bile acidsCeramide synthasesLiver fibrosisNon-alcoholic fatty liver disease

Substanzen

Cers5 protein, mouseSphingosine N-Acyltransferase

Autor:innen und Institutionen

  • Department of Gastroenterology, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, China.
  • Department of Gastroenterology, Yancheng TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, Jiangsu, China.
  • Department of Central Laboratory, Hangzhou Normal University Affiliated Hospital, No.126, Wenzhou Road, Hangzhou, 310000, Zhejiang, China.
  • Department of Gastroenterology, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, China. Electronic address: 1132004868@qq.com.
  • Department of Central Laboratory, Hangzhou Normal University Affiliated Hospital, No.126, Wenzhou Road, Hangzhou, 310000, Zhejiang, China. Electronic address: luoyan9977@163.com.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Basic Public Welfare Research Program of Zhejiang Province

Zitieren

APA

Chen, J., Hao, Y., Xu, P., Bian, D., Han, L., Wu, X., Zhuang, Z., Wang, J., & Luo, Y. (2023). CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications, 667, 120-126. https://doi.org/10.1016/j.bbrc.2023.05.027

Vancouver

Chen J, Hao Y, Xu P, Bian D, Han L, Wu X, et al. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications. 2023;667:120-126. doi:10.1016/j.bbrc.2023.05.027

BibTeX
@article{Chen2023,
  author = {Chen, Jin and Hao, Yanping and Xu, Ping and Bian, Dongxue and Han, Liang and Wu, Xudong and Zhuang, Zhengjie and Wang, Jianhua and Luo, Yan},
  title = {CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {667},
  pages = {120--126},
  doi = {10.1016/j.bbrc.2023.05.027}
}
Kostenlos starten →